GlassScriptPhysician profile
Nga T Pham
NPI 1750838454
$3,856.62
in general payments reported to CMS, 2019-2025
20 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $410 · 2022: $2,135 · 2023: $495 · 2024: $630 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,311.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,937.09 | 2022-2025 | Linq II |
| Pfizer INC. | $446.57 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $354.59 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $231.58 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $135.26 | 2024-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $121.70 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $107.98 | 2022-2025 | Assure Wcd |
| Gilead Sciences, INC. | $85.07 | 2024 | |
| Alexion Pharmaceuticals, INC. | $59.14 | 2023-2024 | Ultomiris |
| Actelion Pharmaceuticals US, INC. | $56.64 | 2021-2023 | Opsumit, Uptravi |
| Esperion Therapeutics, INC. | $53.84 | 2021-2022 | |
| Abbott Laboratories | $45.22 | 2022-2023 | Cardiomems |
| Mallinckrodt Hospital Products INC. | $35.20 | 2024 | Terlivaz |
| Merck Sharp & Dohme LLC | $33.53 | 2022-2023 | Verquvo |
| Amgen INC. | $33.00 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $32.64 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $23.32 | 2021 | |
| Atricure, INC. | $22.91 | 2022 | |
| Amarin Pharma, INC. | $22.48 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.86 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nga Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.